期刊文献+

胺碘酮联合倍他乐克急诊治疗室性心律失常的疗效评价 被引量:20

暂未订购
导出
摘要 目的评价胺碘酮联合倍他乐克急诊治疗室性心律失常的临床疗效。方法选取2010年4月—2013年4月在我院心血管内科门诊和住院的室性心律失常患者70例,采用随机对照方法将其分为观察组和对照组,各35例。观察组给予胺碘酮联合倍他乐克治疗,对照组单独给予倍他乐克治疗,比较两组临床疗效及不良反应情况。结果观察组总有效率为94.3%,高于对照组的80.0%,差异有统计学意义(P<0.05);观察组24h室性期前收缩总次数及短阵室性心动过速发作次数均少于对照组,差异有统计学意义(P<0.05)。结论胺碘酮联合倍他乐克急诊治疗室性心律失常效果显著,能迅速改善患者临床症状,且安全可靠,值得在临床上应用和推广。
作者 高泉水 方杰
出处 《实用心脑肺血管病杂志》 2013年第11期64-65,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献5

二级参考文献16

  • 1Harry A.Efficacy and toxiciyy of amiodarone for the treatments of supraventricular tachyarrhythmias.Prcgress in Cardiorasular Diseases,1989,(51):355.
  • 2王聆训.胺碘酮的毒副反应及防治[J].实用内科杂志,1998,(6):323-323.
  • 3Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Europ Heart J,2001,22:1852-1923.
  • 4Khan IA. Pharmacological cardioversion of recent onset atrial fibrillation . Europ Heart J ,2004,25:1274-1276.
  • 5Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
  • 6Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA Guidlines for the management of patients with ST-Elevation myocardial infarction-Executive Summary. Circulation,2004,110:588-636.
  • 7Hammill SC. Cardiac arrhythmias. J Am Coll Cardiol, 2004, 44 (Suppl Ⅱ): 16A-17A.
  • 8Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med,2000,160:1741-1748.
  • 9The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias. Circulation, 2000, 102(Suppl 8): I 112-128.
  • 10Podrid PJ. Amiodarone: reevaluation of an old drug [ J ]. Ann Intern Med, 1995,122:689 - 700

共引文献193

同被引文献103

  • 1庞小云,剡永利.小剂量胺碘酮联合倍他乐克治疗肥厚型心肌病伴恶性室性心律失常的疗效[J].中国老年学杂志,2014,34(3):779-780. 被引量:33
  • 2汤勇,夏敏刚,蔺曜,朱本银.胺碘酮静脉治疗危重患者并快速房性心律失常30例分析[J].实用心脑肺血管病杂志,2004,12(6):321-322. 被引量:1
  • 3杨宝峰.药理学[M].北京:人民卫生出版社,2010:345.
  • 4陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
  • 5李明俊.胺碘酮联合倍他乐克急诊治疗室性心律失常疗效评价[J].河北联合大学学报(医学版),2011,13(6):795-796.
  • 6徐苏平.胺碘酮联合倍他乐克治疗新发心房扑动疗效分析[J].中国药物经济学,2013,1(20):208-209.
  • 7Van HerendaeI H,Dorian P.Amiodarone for the treatment and preventionof ventricular fibrillation and ventricular tachycardia[J].Vasc Health Risk Manag,2010,6(1):465-472.
  • 8Cochrane A D,Siddins M,Rosenfeldt F L,et al.A comparison ofamiodarone and digoxin for treatment of supraventricular arrhythmias aftercardiac surgery[J].Eur J Cardiothorac Surg,1994,8⑷:194-198.
  • 9Zipes D P,Camm A J,Borggrefe M,et al.ACC/AHA/ESC 2006guidelines for management of patients with ventricular arrhythmias andthe prevention of sudden cardiac death:a report of the American Collegeof Cardiology/American Heart Association Task Force and the EuropeanSociety of Cardiology Committee for Practice Guidelines(writing committeeto develop guidelines for management of patients with ventriculararrhythmias and the prevention of sudden cardiac death):developed incollaboration with the European Heart Rhythm Association and the HeartRhythm Society[J].Circulation,2006,114(10):e385-484.
  • 10Poliak P T,You Y D.Monitoring of hepatic function during amiodaronetherapy[J].Am J Cardiol,2003,91(5):613-616.

引证文献20

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部